ITPS Canada Achieves NATO Flight Training Europe Accreditation 
Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange and Montreal Exchange Closed for Labour Day 
Doubleview Appoints Edward Huebert as Vice President, Permitting, Regulatory & Indigenous Relations 
Focus Graphite and C4V to Evaluate Mine-to-Anode Platform Combining Lac Knife Graphite with C4V’s Green Anode Technology 
Spritzer Sparkling Invites Malaysians to ‘Reset Rasa’ This Merdeka, Rediscover the Flavours That Unite Us Codexis to Report Second Quarter 2021 Financial Results on August 5
REDWOOD CITY, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Brickell Biotech Announces Closing of $8.05 Million Bought Deal Offering of Common Stock, Including Full Exercise of the Underwriter’s Option to Purchase Additional Shares
BOULDER, Colo., July 22, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (Nasdaq: BBI) (the “Company”…
NGM Announces Completion of Enrollment in Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
Geographic atrophy is a progressive, irreversible retinal degenerative disease that can lead to blindness, with…
Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021
SANTA MONICA, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a…
Plus Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
Management to host conference call today at 5:00 pm ET AUSTIN, Texas, July 22, 2021…
MacroGenics Announces Date of Second Quarter 2021 Financial Results Conference Call
ROCKVILLE, MD, July 22, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical…
New U Life Opens Japan as an NFR Market
Lehi, Utah, July 22, 2021 (GLOBE NEWSWIRE) — New U Life Corporation, a health supplements…
AB Science today announced that an abstract reporting results from its Phase 3 AB09004 study on Alzheimer’s disease has been selected for an oral presentation at the annual Alzheimer’s Association International Conference (AAIC)
PRESS RELEASE AB SCIENCE TO PRESENT RESULTS FROM ITS PHASE III AB09004 STUDY IN MILD…
Sanofi: Information concerning the total number of voting rights and shares – June 2021
Information concerning the total number of voting rights and shares, provided pursuant to article L….
Guerbet: Revenue at June 30, 2021
First-half 2021 revenue Strong recovery across all activities Q2 revenue: €186.8 M (+25.1% at…
Foresight Diagnostics’ PhasED-Seq Circulating Tumor DNA Platform Demonstrates Highly Sensitive Minimal Residual Disease (MRD) Detection in B-Cell Lymphomas
Extensive clinical validation in 678 samples from 213 patients with B-cell malignancies Up to 100-fold…
Virbac : Declaration of the number of shares and voting rights June 2021
DECLARATION OF THE NUMBER OF SHARES AND VOTING…
Trigone Pharma to Present Preclinical Data for TRG-100 in Interstitial Cystitis / Bladder Pain Syndrome at the Upcoming American Urological Association Conference (AUA) in September 2021
RAANANA, Israel, July 22, 2021 (GLOBE NEWSWIRE) — Trigone Pharma Ltd., a privately owned biopharmaceutical…
Gelteq Appoints Seasoned Pharma and Tech Executive, James Pekarsky, as Chief Financial Officer
MELBOURNE, Australia, July 22, 2021 (GLOBE NEWSWIRE) — Gelteq Pty Ltd, a global leader in…
Biosplice Publishes Phase 2B Lorecivivint Analysis Showing Clinically Meaningful Benefits to Knee Osteoarthritis Patients
Lorecivivint post-hoc analysis reveals significantly increased likelihood of symptom improvements for knee osteoarthritis compared to…
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Daix (France), July 22, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
22nd Century Group Secures New Contract Manufacturing Agreements, Expands Distribution Network and Manufacturing Capabilities Ahead of VLN® Launch
Company will Increase Investment in Tobacco Production and Testing Equipment and Add New Talent in…
LIXTE BIOTECHNOLOGY COMMENTS ON REPORT THAT ITS PP2A INHIBITOR LB-100 COMBINED WITH ANOTHER INVESTIGATIONAL AGENT STIMULATES BONE GROWTH IN MODELS OF DWARFISM
Altadena, CA, July 22, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq:LIXTE) a clinical-stage…
Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor Claim
New twice-a-day dosing regimen allows for daily immune system support Company intends to create a…
Parexel Announces Innovative Partnership with Rare Disease Foundation in China
Collaboration with Beijing Illness Challenge Foundation seeks to empower patients and improve clinical trial experience…